¼¼°èÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Viral Vector Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1786545
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 245 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 6,959,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,164,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 11,836,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Persistence Market Research´Â ÃÖ±Ù ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ¼¼°è ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, °úÁ¦ µî Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ°í ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå : Á¶»ç ¹üÀ§

¹ÙÀÌ·¯½º º¤ÅÍ ¹é½ÅÀº º¯ÇüµÈ ¹ÙÀÌ·¯½º¸¦ ÀÌ¿ëÇÏ¿© À¯Àü ¹°ÁúÀ» ¼¼Æ÷¿¡ µµÀÔÇÏ¿© °ß°íÇÑ ¸é¿ª ¹ÝÀÀÀ» ÀÚ±ØÇÕ´Ï´Ù. ÀÌµé ¹é½ÅÀº ƯÈ÷ ¿¡º¼¶ó ÃâÇ÷¿­, COVID-19, ÁöÄ«¿­ µîÀÇ °¨¿°Áõ°ú Á¾¾çÇÐ, Èñ¼ÒÀ¯Àü¼º Áúȯ°úÀÇ ½Î¿ò¿¡¼­ ³ôÀº È¿´É°ú ¹ü¿ë¼ºÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ¾Æµ¥³ë¹ÙÀÌ·¯½º, ·»Æ¼¹ÙÀÌ·¯½º, ·¹Æ®·Î¹ÙÀÌ·¯½º µîÀÌ Æ÷ÇÔµÇ¾î °øÁߺ¸°Ç ÇÁ·Î±×·¥, º´¿ø, »ý¸í°øÇбâ¾÷, ¿¬±¸±â°ü¿¡ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ¼ºÀåÀÇ ¿øµ¿·ÂÀº °¨¿°ÁõÀÇ ¸¸¿¬ Áõ°¡, ¹é½Å ±â¼úÀÇ Áøº¸, ÁöÁöÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©ÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ :

¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ¼¼°è ½ÃÀåÀº °¨¿°¿¡ ÀÇÇÑ ¼¼°è ºÎ´ã Áõ°¡¿Í ½Å¼Ó ´ëÀÀ ¹é½Å Ç÷§ÆûÀÇ Çʿ伺¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ¾Æµ¥³ë¹ÙÀÌ·¯½º º¤Å͸¦ ±â¹ÝÀ¸·Î ÇÑ COVID-19 ¹é½ÅÀÇ ¼º°øÀÌ ÀÔÁõµÊ¿¡ µû¶ó, ÀÌ Áö¿ª¿¡ ´ëÇÑ ÅõÀÚ°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. º¤ÅÍ ¼³°è, ¾ÈÀü °­È­, È®Àå °¡´ÉÇÑ Á¦Á¶ °øÁ¤ÀÇ ±â¼úÀû Áøº¸´Â ¹é½ÅÀÇ È¿´ÉÀ» ³ôÀÌ°í °³¹ß ±â°£À» ´ÜÃàÇÕ´Ï´Ù. ¶ÇÇÑ, ¹é½Å ¿¬±¸¸¦ À§ÇÑ Á¤ºÎ Àڱݰú °ü¹Î ÆÄÆ®³Ê½ÊÀÇ È®´ë°¡ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. °³º°È­ ¾Ï ¹é½Å°ú À¯ÀüÀÚ Ä¡·á ÀÀ¿ë¿¡ ´ëÇÑ ¼ö¿ä°¡ ½ÃÀå Àü¸ÁÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ :

Å« ¼ºÀåÀÇ °¡´É¼º¿¡µµ ºÒ±¸Çϰí, ½ÃÀåÀº ¸î °¡Áö ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ³ôÀº Á¦Á¶ ºñ¿ë, º¹ÀâÇÑ Á¦Á¶ °øÁ¤ ¹× ÄݵåüÀÎ ¹°·ù´Â ÀúÀÚ¿ø ȯ°æ¿¡¼­ÀÇ Á¢±Ù¼ºÀ» Á¦ÇÑÇÕ´Ï´Ù. À¯ÀüÀÚ º¯Çü À¯±âüÀÇ »ç¿ë°ú °ü·ÃµÈ ±ÔÁ¦ Àå¾Ö¹°, ¸é¿ª¿ø¼º ¹× º¤ÅÍ¿¡ ÀÇÇÑ ºÎÀÛ¿ë¿¡ ´ëÇÑ ÀáÀçÀûÀÎ ¿ì·Á´Â Á¦Ç° ½ÂÀο¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÅÈï±¹ÀÇ ÁöÀûÀç»ê Á¦¾à°ú »ý»ê ´É·ÂÀÇ ÇѰè´Â ½ÃÀå ħÅõ¿Í ±â¼ú Çõ½ÅÀÇ º¸±ÞÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ :

¹ÙÀÌ·¯½º º¤ÅÍ ¹é½ÅÀº º¤ÅÍ ¿£Áö´Ï¾î¸µ, mRNA¿Í º¤ÅÍÀÇ Á¶ÇÕ Ç÷§Æû, ³»¿­¼º ¹é½Å Á¦Çü µîÀÇ Çõ½ÅÀ» ÅëÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¾Ï°ú ÀÚ°¡ ¸é¿ª ÁúȯÀÇ Ä¡·á ¹é½ÅÀ¸·ÎÀÇ ÁøÃâÀº »õ·Î¿î ¼öÀÍ¿øÀ» ¿±´Ï´Ù. °³¹ß ¹× Á¦Á¶ ¼öʱâ°ü(CDMO)°úÀÇ Á¦ÈÞ, Áö¿ª Á¦Á¶ Çãºê¿¡ ´ëÇÑ ÅõÀÚ, ¹é½Å ¼³°è¿¡ À־ÀÇ AIÀÇ ÅëÇÕ¿¡ ÀÇÇØ ¾÷¹«°¡ ÇÕ¸®È­µÇ¾î, ºñ¿ë È¿À²ÀÌ Çâ»óÇÕ´Ï´Ù. Àü¿°º´¿¡ ´ëºñÇÏ°í ½ÅÈï °¨¿°ÀÇ À§Çù¿¡ ´ëÇÑ ¼¼°è °Ç°­ ±â°üÀÇ Áö¼ÓÀûÀÎ Áö¿øÀº ½ÃÀå Àü¸ÁÀ» ´õ¿í È®´ëÇÕ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ

Á¦4Àå °¡°Ý µ¿Ç⠺м®, 2019³â-2032³â

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦6Àå ¼¼°è ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : Áö¿ª

Á¦7Àå ºÏ¹ÌÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦8Àå À¯·´ÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦9Àå µ¿¾Æ½Ã¾Æ ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦10Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹ÙÀÌ·¯½º º¤ÅÍ ¹é½Å ½ÃÀå Àü¸Á : ½ÇÀû(2019³â-2024³â) ¹× ¿¹Ãø(2025³â-2032³â)

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the worldwide market for viral vector vaccines. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Viral Vector Vaccines Market - Report Scope:

Viral vector vaccines utilize modified viruses to deliver genetic material into cells, stimulating robust immune responses. These vaccines have demonstrated high efficacy and versatility, particularly in combating infectious diseases such as Ebola, COVID-19, and Zika, as well as in oncology and rare genetic disorders. The market encompasses adenoviral, lentiviral, retroviral, and others, serving public health programs, hospitals, biotechnology firms, and research institutions. Growth is fueled by the increasing prevalence of infectious diseases, advancements in vaccine technology, and supportive regulatory frameworks.

Market Growth Drivers:

The global viral vector vaccines market is propelled by the rising global burden of infectious diseases and the need for rapid-response vaccine platforms. The proven success of adenoviral vector-based COVID-19 vaccines has accelerated investments in this domain. Technological advances in vector design, safety enhancements, and scalable manufacturing processes are enhancing vaccine efficacy and reducing development timelines. Additionally, growing government funding and public-private partnerships for vaccine research support market expansion. Demand for personalized cancer vaccines and gene therapy applications further bolsters the market outlook.

Market Restraints:

Despite strong growth potential, the market faces several challenges. High production costs, complex manufacturing processes, and cold chain logistics limit accessibility in low-resource settings. Regulatory hurdles related to the use of genetically modified organisms and potential concerns about immunogenicity and vector-induced adverse effects may impact product approvals. Moreover, intellectual property constraints and limited production capacity in emerging economies can impede market penetration and innovation diffusion.

Market Opportunities:

The viral vector vaccines market offers substantial growth opportunities through innovations in vector engineering, mRNA-vector combination platforms, and thermostable vaccine formulations. Expansion into therapeutic vaccines for cancer and autoimmune disorders opens new revenue streams. Collaborations with contract development and manufacturing organizations (CDMOs), investment in regional manufacturing hubs, and integration of AI in vaccine design streamline operations and enhance cost efficiency. Continued support from global health organizations for pandemic preparedness and emerging infectious disease threats further amplifies market prospects.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

These companies invest in R&D to develop next-generation vectors with improved safety and efficacy profiles. Collaborations with academic institutions and global health organizations facilitate access to novel targets and accelerate clinical translation. Partnerships with CDMOs enable flexible and rapid-scale production. Emphasis on regulatory compliance, patient safety, and global distribution enhances market presence and supports long-term growth.

Key Companies Profiled:

Viral Vector Vaccines Market Research Segmentation:

By Patient:

By Distribution Channel:

By Region:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Dynamics

4. Price Trend Analysis, 2019-2032

5. Global Viral Vector Vaccines Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

6. Global Viral Vector Vaccines Market Outlook: Region

7. North America Viral Vector Vaccines Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

8. Europe Viral Vector Vaccines Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

9. East Asia Viral Vector Vaccines Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

10. South Asia & Oceania Viral Vector Vaccines Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

11. Latin America Viral Vector Vaccines Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

12. Middle East & Africa Viral Vector Vaccines Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

13. Competition Landscape

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â